Yuhan Corp represents values and corporate philosophy centered around innovation, excellence, and ethical business practices. As a leading pharmaceutical and chemical company in South Korea, Yuhan Corp strives to provide innovative solutions for various healthcare needs. With a strong commitment to research and development, the company aims to enhance the quality of life by developing and commercializing safe and effective pharmaceutical products. Yuhan Corp also emphasizes sustainability and corporate social responsibility, aiming to contribute to a healthier society and environment. With a focus on customer satisfaction and continuous improvement, Yuhan Corp remains dedicated to delivering value and advancing the healthcare industry.

Yuhan Corp is primarily present in South Korea.

Yuhan Corp has achieved several significant milestones throughout its history. Some noteworthy achievements include the successful development and launch of innovative pharmaceutical products in various therapeutic areas. The company has also established strategic partnerships with global pharmaceutical organizations, expanding its global presence and promoting international collaborations. Yuhan Corp's commitment to research and development has resulted in groundbreaking advancements and the introduction of cutting-edge technologies. Additionally, it has received recognition for its sustainable business practices and contributions to societal welfare. Overall, Yuhan Corp's remarkable milestones highlight its dedication to advancing healthcare and its continuous pursuit of excellence in the pharmaceutical industry.

Yuhan Corp, a leading pharmaceutical company, has a rich and extensive history. Established in 1926, it has grown to become an integral part of the healthcare industry in South Korea. Over the years, Yuhan Corp has been committed to enhancing the well-being of individuals through innovative and high-quality healthcare products. With a diverse product portfolio covering areas such as pharmaceuticals, animal health, and personal care, Yuhan Corp has established itself as a trusted brand both domestically and internationally. Continuously adapting to market demands and leveraging its research and development capabilities, Yuhan Corp strives to contribute to the improvement of global healthcare.

The main competitors of Yuhan Corp in the market include Hanmi Pharmaceutical Co., Ltd., CJ Healthcare Corp., and Daewoong Pharmaceutical Co., Ltd.

Yuhan Corp is primarily active in the pharmaceutical industry.

The business model of Yuhan Corp revolves around its core operations in the pharmaceutical industry. As a leading South Korean company, Yuhan Corp focuses on researching, developing, manufacturing, and marketing various pharmaceutical products. Its diverse portfolio includes prescription drugs, over-the-counter medications, and medical devices. By combining innovation, cutting-edge technology, and strategic partnerships, Yuhan Corp aims to address unmet medical needs and improve the overall health and well-being of individuals. With a strong emphasis on research and development, the company continually strives to deliver high-quality and effective healthcare solutions to customers worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ Yuhan هو ٦٣٫٠٥.

مُعامِل القيمة إلى المبيعات Yuhan هو ٤٫٤١.

نقاط جودة AlleAktien لـ Yuhan هي 4/10.

المتوقعة Yuhan الإيرادات هي ٢٫١٢ السيرة الذاتية. KRW.

صافي الربح المتوقعة Yuhan هو ١٤٨٫١٤ مليارات KRW.

Yuhan Corporation is a South Korean company that was founded in 1926 and operates in various business sectors. The company is active in the pharmaceutical, health & wellness, and chemical industries. Pharmaceuticals Yuhan Corp primarily focuses on the development and manufacturing of innovative drugs, particularly for the treatment of cancer and neurological diseases. The company is able to effectively conduct research and development as over half of its employees work in this field. In addition to the pharmaceutical industry, the company also works as a distributor for international pharmaceutical companies such as Eli Lilly and Sanofi. Health & Wellness Yuhan Corp is also active in the health and wellness industry. The company operates a comprehensive health center and offers a variety of services and products to promote the health of customers and patients. The products offered include dietary supplements, health drinks, and personal care products. Chemicals Yuhan Corp also has a business segment for chemical products. The company produces a variety of chemicals, particularly for the manufacture of authentication concepts for the electronics industry and dyes for the textile industry. The chemical division of Yuhan aims to implement sustainable production methods to develop more environmentally-friendly solutions for the industry. In summary, Yuhan Corp is a diverse company that operates in various sectors. The company has enhanced its strategies in research and development, product development, and marketing to strengthen its presence in the global market. With a combination of expertise, technological innovation, and a commitment to sustainability, Yuhan Corp has solidified its status as a leading company in the industry and will continue to do so.

يوزع Yuhan أرباحًا قدرها ٣٨٠٫٩٥ KRW من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Yuhan في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـYuhan هو KR7000100008.

الرمز المُختصر لـ Yuhan هو 000100.KS.

خلال آخر 12 شهراً، دفعت Yuhan توزيعات أرباح بقيمة ٤٢٨٫٥٧ KRW . وهذا يعادل عائد توزيعات أرباح يقارب ٠٫٣٦ %. ومن المتوقع أن تدفع Yuhan خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٤٤٣٫٣٦ KRW.

نسبة توزيعات الأرباح الحالية لـ Yuhan هي ٠٫٣٦ %.

Yuhan يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يناير, يناير, يناير, يناير.

Yuhan دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٤٤٣٫٣٦ KRW. وهذا يعادل عائد توزيعات أرباح قدره ٠٫٣٧ %.

Yuhan يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٤٢٨٫٥٧١ KRW من Yuhan المُعلن عنها في ١‏/٥‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٧‏/١٢‏/٢٠٢٣.

تم توزيع آخر دفعة من الأرباح بتاريخ ١‏/٥‏/٢٠٢٤.

في العام 2023، وزعت Yuhan ٣٨٠٫٩٥٢ KRW كأرباح أسهم.

يتم توزيع أرباح Yuhan بالعملة KRW.